Reference
[Please submit your publication]
|
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
5 |
NM_141383.1 |
CG15189-RA (Osi19), mRNA |
0 |
0 |
3 |
6 |
5 |
NM_001042801.1 |
CG34104-RB, transcript variant B (CG34104), mRNA |
0 |
0 |
3 |
6 |
5 |
NM_001042802.1 |
CG34104-RA, transcript variant A (CG34104), mRNA |
0 |
0 |
3 |
3 |
4 |
NM_079595.2 |
CG6920-RA (mus309), mRNA |
0 |
0 |
3 |
3 |
4 |
NM_132335.2 |
CG12139-RB (CG12139), mRNA |
0 |
0 |
3 |
2 |
7 |
NM_080138.2 |
CG1618-RA (comt), mRNA |
0 |
0 |
3 |
2 |
3 |
NM_143052.2 |
CG10845-RA (CG10845), mRNA |
0 |
0 |
2 |
7 |
5 |
NM_206576.1 |
CG6095-RB, transcript variant B (CG6095), mRNA |
0 |
0 |
2 |
7 |
5 |
NM_143197.1 |
CG6095-RA, transcript variant A (CG6095), mRNA |
0 |
0 |
2 |
4 |
2 |
NM_166674.1 |
CG4589-RA, transcript variant A (CG4589), mRNA |
0 |
0 |
2 |
4 |
2 |
NM_138078.2 |
CG4589-RB, transcript variant B (CG4589), mRNA |
0 |
0 |
2 |
4 |
2 |
NM_166675.1 |
CG4589-RC, transcript variant C (CG4589), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_136388.2 |
CG3268-RA (phtf), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_142926.3 |
CG10374-RC, transcript variant C (Lsd-1), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_170093.2 |
CG10374-RB, transcript variant B (Lsd-1), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_170092.2 |
CG10374-RA, transcript variant A (Lsd-1), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_168952.2 |
CG11471-RA, transcript variant A (Aats-ile), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_176387.1 |
CG11471-RD, transcript variant D (Aats-ile), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_080101.3 |
CG11471-RC, transcript variant C (Aats-ile), mRNA |
0 |
0 |
1 |
7 |
4 |
NM_132114.1 |
CG14442-RA (CG14442), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_168569.1 |
CG8937-RD, transcript variant D (Hsc70-1), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_079339.2 |
CG8937-RA, transcript variant A (Hsc70-1), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_168568.2 |
CG8937-RC, transcript variant C (Hsc70-1), mRNA |
0 |
0 |
1 |
3 |
25 |
NM_175960.3 |
CG33196-RB (dp), mRNA |
0 |
0 |
1 |
3 |
9 |
NM_141725.1 |
CG6241-RA (CG6241), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_134923.1 |
CG15408-RA (CG15408), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_001014545.1 |
CG33519-RB (Unc-89), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_057551.3 |
CG13521-RA, transcript variant A (robo), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_166543.1 |
CG13521-RB, transcript variant B (robo), mRNA |
0 |
0 |
0 |
10 |
14 |
NM_168386.1 |
CG8108-RA, transcript variant A (CG8108), mRNA |
|